Controlled delivery of fibroblast growth factor-9 from biodegradable poly(ester amide) fibers for building functional neovasculature

Pharmaceutical Research

Volumn 31, Issue 12, 2014, Pages 3335-3347

  Said, Somiraa S ^a   Pickering, J Geoffrey ^a   Mequanint, Kibret ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Electrospinning; Fibroblast growth factor 9; Poly(ester amide)s; Therapeutic angiogenesis

Indexed keywords

AMIDE; DELAYED RELEASE FORMULATION; FIBROBLAST GROWTH FACTOR 9; POLYESTER;

3T3 CELL LINE; ANGIOGENESIS; ANIMAL; CELL SURVIVAL; CONFOCAL MICROSCOPY; CORONARY BLOOD VESSEL; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; MOUSE; VASCULAR SMOOTH MUSCLE;

AMIDES; ANIMALS; CELL SURVIVAL; CORONARY VESSELS; DELAYED-ACTION PREPARATIONS; FIBROBLAST GROWTH FACTOR 9; MICE; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; NIH 3T3 CELLS; POLYESTERS;

EID: 84922579191     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1423-2     Document Type: Article

References (41)

1. Dragneva G, Korpisalo P, Yla-Herttuala S. Promoting Blood Vessel Growth in Ischemic Diseases: Challenges in Translating Preclinical Potential into Clinical Success. Dis Model Mech. 2013;6(2):312-22.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-41.
3. Lee KY, Peters MC, Mooney DJ. Comparison of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis in SCID Mice. J Control Release. 2003;87(1-3):49-56.
4. Said SS, Pickering JG, Mequanint K. Advances in Growth Factor Delivery for Therapeutic Angiogenesis. J Vasc Res. 2013;50(1):35-51.
5. Sahoo S, Ang LT, Goh JC-H, Toh SL. Growth Factor Delivery Through Electrospun Nanofibers in Scaffolds for Tissue Engineering Applications. J Biomed Mater Res. 2010;93A:1539-50.
6. Yang Y, Xia T, Zhi W, Wei L, Weng J, Zhang C, et al. Promotion of Skin Regeneration in Diabetic Rats by Electrospun Core-Sheath Fibers Loaded With Basic Fibroblast Growth Factor. Biomaterials. 2011;32(18):4243-54.
7. Seyednejad H, Ji W, Yang F, van Nostrum CF, Vermonden T, van den Beucken JJ, et al. Coaxially Electrospun Scaffolds Based on Hydroxyl-Functionalized Poly (Epsilon-Caprolactone) and Loaded With VEGF for Tissue Engineering Applications. Biomacromolecules. 2012;13(11):3650-60.
8. Roy RS, Roy B, Sengupta S. Emerging Technologies for Enabling Proangiogenic Therapy. Nanotechnology. 2011;22(49):494004.
9. Rubanyi GM. Angiogenesis in health and disease: Basic mechanisms and clinical applications. New york: Marcel Dekker Inc.; 2000.
10. Agrotis A, Kanellakis P, Kostolias G, Di Vitto G, Wei C, Hannan R, et al. Proliferation of Neointimal Smooth Muscle Cells After Arterial Injury. Dependence on Interactions Between Fibroblast Growth Factor Receptor-2 and Fibroblast Growth Factor-9. J Biol Chem. 2004;279(40):42221-9.
11. Spicer D. FGF9 on the Move. Nat Genet. 2009;41(3):272-3.
12. Frontini MJ, Nong Z, Gros R, Drangova M, O'Neil C, Rahman MN, et al. Fibroblast Growth Factor 9 Delivery During Angiogenesis Produces Durable, Vasoresponsive Microvessels Wrapped by Smooth Muscle Cells. Nat Biotechnol. 2011;29(5):421-7.
13. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric System for Dual Growth Factor Delivery. Nat Biotechnol. 2001;19(11):1029-34.
14. Knight DK, Gillies ER, Mequanint K. Strategies in Functional Poly (ester amide) Syntheses to Study Human Coronary Artery Smooth Muscle Cell Interactions. Biomacromolecules. 2011;12(7):2475-87.
15. Vert M, Li S, Garreau H. New Insights on the Degradation of Bioresorbable Polymeric Devices Based on Lactic and Glycolic Acids. Clin Mater. 1992;10(1-2):3-8.
16. Szentivanyi A, Chakradeo T, Zernetsch H, Glasmacher B. Electrospun Cellular Microenvironments: Understanding Controlled Release and Scaffold Structure. Adv Drug Delivery Rev. 2011;63(4-5):209-20.
17. Li L, Chu CC. Nitroxyl Radical Incorporated Electrospun Biodegradable Poly (Ester Amide) Nanofiber Membranes. J Biomater Sci Polym Ed. 2009;20(3):341-61.
18. Srinath D, Lin S, Knight DK, Rizkalla AS, Mequanint K. Fibrous Biodegradable L-alanine-based Scaffolds for Vascular Tissue Engineering. J Tissue Eng Regen Med. 2012.
19. Valle L, Roa M, Diaz A, Casas M, Puiggali J, Rodriguez-Galan A. Electrospun Nanofibers of a Degradable Poly (Ester amide). Scaffolds Loaded with Antimicrobial Agents. J Polym Res. 2012;19(2):1-13.
20. Morgan PW. Interfacial Polymerization. Encyclopedia of Polymer Science and Technology: John Wiley & Sons, Inc.; 2002.
21. Pham QP, Sharma U, Mikos AG. Electrospinning of Polymeric Nanofibers for Tissue Engineering Applications: A Review. Tissue Eng. 2006;12(5):1197-211.
22. Zong X, Kim K, Fang D, Ran S, Hsiao BS, Chu B. Structure and Process Relationship of Electrospun Bioabsorbable Nanofiber Membranes. Polymer. 2002;43(16):4403-12.
23. Jarusuwannapoom T, Hongrojjanawiwat W, Jitjaicham S, Wannatong L, Nithitanakul M, Pattamaprom C, et al. Effect of Solvents on Electro-Spinnability of Polystyrene Solutions and Morphological Appearance of Resulting Electrospun Polystyrene Fibers. Eur Polym J. 2005;41(3):409-21.
24. Tsitlanadze G, Machaidze M, Kviria T, Djavakhishvili N, Chu CC, Katsarava R. Biodegradation of Amino-Acid-Based Poly (Ester Amide)s: In Vitro Weight Loss and Preliminary in Vivo Studies. J Biomater Sci Polym Ed. 2004;15(1):1-24.
25. Zamani M, Morshed M, Varshosaz J, Jannesari M. Controlled Release of Metronidazole Benzoate from Poly Epsilon-Caprolactone Electrospun Nanofibers for Periodontal Diseases. Eur J Pharm Biopharm. 2010;75(2):179-85.
26. Zeng J, Yang L, Liang Q, Zhang X, Guan H, Xu X, et al. Influence of the Drug Compatibility With Polymer Solution on the Release Kinetics of Electrospun Fiber Formulation. J Control Release. 2005;105(1-2):43-51.
27. Maretschek S, Greiner A, Kissel T. Electrospun Biodegradable Nanofiber Nonwovens for Controlled Release of Proteins. J Control Release. 2008;127(2):180-7.
28. Sy JC, Klemm AS, Shastri VP. Emulsion as a Means of Controlling Electrospinning of Polymers. Adv Mater. 2009;21(18):1814-9.
29. Yang Y, Li X, He S, Cheng L, Chen F, Zhou S, et al. Biodegradable Ultrafine Fibers With Core-Sheath Structures for Protein Delivery and its Optimization. Polym Adv Technol. 2011;22(12):1842-50.
30. Ritger PL, Peppas NA. A Simple Equation for Description of Solute Release I. Fickian and non-Fickian Release from non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Discs. J Control Release. 1986;5(1):23-36.
31. Baker SC, Southgate J. Towards Control of Smooth Muscle Cell Differentiation in Synthetic 3D Scaffolds. Biomaterials. 2008;29(23):3357-66.
32. Naruo K, Seko C, Kuroshima K, Matsutani E, Sasada R, Kondo T, et al. Novel Secretory Heparin-Binding Factors from Human Glioma Cells (Glia-Activating Factors) Involved in Glial Cell Growth. Purification and Biological Properties. J Biol Chem. 1993;268(4):2857-64.
33. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, et al. A Broad-Spectrum Human Lung Fibroblast-Derived Mitogen is a Variant of Hepatocyte Growth Factor. Proc Natl Acad Sci. 1991;88(2):415-9.
34. Richardson WJ, Wilson E, Moore Jr JE. Altered Phenotypic Gene Expression of 10T1/2 Mesenchymal Cells in Nonuniformly Stretched PEGDA Hydrogels. Am J Physiol Cell Physiol. 2013;305(1):C100-110.
35. Horwitz JA, Shum KM, Bodle JC, Deng M, Chu CC, Reinhart-King CA. Biological Performance of Biodegradable Amino Acid-Based Poly (Ester Amide)s: Endothelial Cell Adhesion and Inflammation In Vitro. J Biomed Mater Res A. 2010;95(2):371-80.
36. Deng M, Wu J, Reinhart-King CA, Chu CC. Biodegradable Functional Poly (Ester Amide)s With Pendant Hydroxyl Functional Groups: Synthesis, Characterization, Fabrication and In Vitro Cellular Response. Acta Biomater. 2011;7(4):1504-15.
37. Lin S, Sandig M, Mequanint K. Three-Dimensional Topography of Synthetic Scaffolds Induces Elastin Synthesis by Human Coronary Artery Smooth Muscle Cells. Tissue Eng Part A. 2011;17(11-12):1561-71.
38. Carlson AL, Florek CA, Kim JJ, Neubauer T, Moore JC, Cohen RI, et al. Microfibrous Substrate Geometry as a Critical Trigger for Organization, Self-Renewal, and Differentiation of Human Embryonic Stem Cells Within Synthetic 3-Dimensional Microenvironments. Faseb J. 2012;26(8):3240-51.
39. Zhou L, Takayama Y, Boucher P, Tallquist MD, Herz J. LRP1 Regulates Architecture of the Vascular Wall by Controlling PDGFRÎ2-Dependent Phosphatidylinositol 3-Kinase Activation. PLoS One. 2009;4(9):e6922.
40. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-Beta in Recruitment of Vascular Smooth Muscle Cells and Pericytes During Embryonic Blood Vessel Formation in the Mouse. Development. 1999;126(14):3047-55.
41. Zhang H, Jia X, Han F, Zhao J, Zhao Y, Fan Y, et al. Dual-Delivery of VEGF and PDGF by Double-Layered Electrospun Membranes for Blood Vessel Regeneration. Biomaterials. 2012;34(9):2202-12.